StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)

Research analysts at StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report released on Thursday. The firm set a “hold” rating on the stock.

TherapeuticsMD Price Performance

Shares of NASDAQ TXMD opened at $1.01 on Thursday. TherapeuticsMD has a twelve month low of $0.70 and a twelve month high of $2.44. The firm has a 50-day moving average of $0.92 and a two-hundred day moving average of $1.17.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.